IRCCS Istituto delle Scienze Neurologiche
Bologna, Italy
Research institute in Bologna
Padiglione G, Via Altura, 3, 40139 Bologna BO
About IRCCS Istituto delle Scienze Neurologiche
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Azienda Usl di Bologna
2
Stealth BioTherapeutics Inc.
2
Reneo Pharma Ltd
1
Clinical Trials at IRCCS Istituto delle Scienze Neurologiche
During the past decade, IRCCS Istituto delle Scienze Neurologiche conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension
2017-10-09
2020-02-10
Terminated
218
A Study of the Efficacy and Safety of 24 Week Treatment With REN001 in Patients With Primary Mitochondrial Myopathy
2021-05-21
2023-10-01
Recruiting
200
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)
2022-04-29
2024-07-01
Recruiting
130
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Istituto delle Scienze Neurologiche"
#1 collaborator was "IRCCS Azienda Ospedaliero-Universitaria di Bologna" with 1 trials as a collaborator, "IRCCS-Istituto delle scienze neurologiche di Bologna" with 1 trials as a collaborator, "Ministero della Salute, Italy" with 1 trials as a collaborator and "University of Bologna" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at IRCCS Istituto delle Scienze Neurologiche
According to Clinical.Site data, the most researched conditions in "IRCCS Istituto delle Scienze Neurologiche" are
"Primary Mitochondrial Myopathy" (2 trials), "Acquired Brain Injury" (1 trials), "Hemorrhagic Stroke" (1 trials), "Ischemic Stroke" (1 trials) and "Mitochondrial Complex I Deficiency" (1 trials). Many other conditions were trialed in "IRCCS Istituto delle Scienze Neurologiche" in a lesser frequency.
Clinical Trials Intervention Types at IRCCS Istituto delle Scienze Neurologiche
Most popular intervention types in "IRCCS Istituto delle Scienze Neurologiche" are "Drug" (2 trials), "Procedure" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "CP group" (1 trials), "Elamipretide" (1 trials), "REN001" (1 trials) and "Standard care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IRCCS Istituto delle Scienze Neurologiche
The vast majority of trials in "IRCCS Istituto delle Scienze Neurologiche" are
5 trials for "All" genders.
Clinical Trials Status at IRCCS Istituto delle Scienze Neurologiche
Currently, there are NaN active trials in "IRCCS Istituto delle Scienze Neurologiche".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in IRCCS Istituto delle Scienze Neurologiche,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS Istituto delle Scienze Neurologiche, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".